|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.85 USD | -3.55% |
|
+1.73% | +19.37% |
| 05-11 | Cytokinetics Announces New Data Related to MYQORZO At ESC Heart Failure 2026 | CI |
| 05-07 | Cytokinetics Prices Upsized $700 Million Share Offering | MT |
| Capitalization | 10.21B 8.77B 8.02B 7.62B 14.03B 983B 14.27B 96.04B 37.22B 465B 38.31B 37.5B 1,622B | P/E ratio 2026 * |
-11.6x | P/E ratio 2027 * | -16.2x |
|---|---|---|---|---|---|
| Enterprise value | 9.13B 7.85B 7.18B 6.82B 12.56B 880B 12.77B 85.94B 33.31B 416B 34.28B 33.55B 1,451B | EV / Sales 2026 * |
84.5x | EV / Sales 2027 * | 23.7x |
| Free-Float |
98.24% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytokinetics, Incorporated
| 1 day | -3.55% | ||
| 1 week | +1.73% | ||
| Current month | +18.57% | ||
| 1 month | +13.70% | ||
| 3 months | +13.24% | ||
| 6 months | +14.65% | ||
| Current year | +19.37% |
| 1 week | 74.3 |  | 78.84 |
| 1 month | 58.64 | | 80.2 |
| Current year | 58.43 | | 80.2 |
| 1 year | 29.81 | | 80.2 |
| 3 years | 25.98 | | 110.25 |
| 5 years | 17.72 | | 110.25 |
| 10 years | 5.75 | | 110.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 62 | 01/01/2007 |
Sung Lee
DFI | Director of Finance/CFO | 56 | 08/05/2024 |
| Chief Administrative Officer | 57 | 14/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Blum
BRD | Director/Board Member | 62 | 01/01/2007 |
John Henderson
CHM | Chairman | 81 | 08/04/2022 |
Wendell Wierenga
BRD | Director/Board Member | 78 | 09/02/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.55% | +1.73% | +144.68% | +101.84% | 10.3B | |
| -2.54% | -2.26% | +33.94% | +75.07% | 50.1B | |
| -1.05% | -4.45% | +66.31% | +50.52% | 45.82B | |
| -1.82% | +3.14% | +57.30% | +469.34% | 23.66B | |
| -0.78% | -4.81% | -4.23% | -15.34% | 22.65B | |
| -2.20% | +0.86% | +39.87% | -26.56% | 17.8B | |
| +0.39% | +2.99% | +27.97% | -40.10% | 16.08B | |
| -5.32% | -15.07% | +36.29% | +202.26% | 14.14B | |
| -5.04% | -14.15% | -32.89% | +888.89% | 13.09B | |
| -2.84% | -5.14% | +32.07% | - | 13B | |
| Average | -2.47% | -4.26% | +40.13% | +189.55% | 22.66B | |
| Weighted average by Cap. | -2.13% | -4.70% | +40.36% | +146.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 108M 92.81M 84.92M 80.65M 148M 10.41B 151M 1.02B 394M 4.92B 405M 397M 17.16B | 388M 333M 305M 290M 533M 37.37B 542M 3.65B 1.41B 17.68B 1.46B 1.42B 61.63B |
| Net income | -806M -692M -634M -602M -1.11B -77.64B -1.13B -7.58B -2.94B -36.74B -3.02B -2.96B -128B | -653M -561M -513M -487M -897M -62.89B -913M -6.14B -2.38B -29.76B -2.45B -2.4B -104B |
| Net Debt | -1.07B -923M -844M -802M -1.48B -103B -1.5B -10.11B -3.92B -48.95B -4.03B -3.95B -171B | -998M -857M -784M -745M -1.37B -96.12B -1.39B -9.39B -3.64B -45.48B -3.74B -3.67B -159B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/05/26 | 75.18 $ | -0.88% | 1,798,135 |
| 15/05/26 | 75.85 $ | -3.55% | 1,829,793 |
| 14/05/26 | 78.64 $ | +1.84% | 2,349,146 |
| 13/05/26 | 77.22 $ | +3.22% | 2,214,747 |
| 12/05/26 | 74.81 $ | +0.34% | 2,418,515 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CYTK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition